These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12170074)

  • 1. Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa.
    Svartholm E; Annerhagen V; Länne T
    Anesthesiology; 2002 Jun; 96(6):1528. PubMed ID: 12170074
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
    Stefanović B; Stefanović B; Mijatović S; Radenković D; Popović N; Sijacki A; Lacković V
    Vojnosanit Pregl; 2009 Nov; 66(11):928-32. PubMed ID: 20017427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis.
    Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Palacios-Ortega F; Gómez A
    Pancreas; 2005 Oct; 31(3):292-4. PubMed ID: 16163065
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
    Schuster R; Lee SJ; Rink D
    Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 43-year-old man was admitted to the hospital with the diagnosis of acute pancreatitis of 4 days' duration.
    Wordliczek J; Serednicki W; Grabowska I; Szczepanik AM; Nowak W; Popiela T
    Pancreas; 2003 Jan; 26(1):101-2. PubMed ID: 12499928
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
    Holcomb JB; Neville HL; Fischer CF; Hoots K
    Curr Surg; 2003; 60(4):423-7. PubMed ID: 14972234
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant factor VIIa treatment of bleeding associated with acute renal failure.
    Moisescu E; Ardelean L; Simion I; Mureşan A; Ciupan R
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):575-7. PubMed ID: 10997798
    [No Abstract]   [Full Text] [Related]  

  • 8. [Haemorrhagic shock complicating acute pancreatitis].
    Duszyńiska W; Lipińska-Gediga M; Domosławski P; Kaiser T; Durek G; Bednarz W
    Anestezjol Intens Ter; 2011; 43(1):36-9. PubMed ID: 21786529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome.
    Faber P; Craig WL; Duncan JL; Holliday K
    Acta Anaesthesiol Scand; 2007 Oct; 51(9):1277-9. PubMed ID: 17714577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, controlled study to explore the efficacy of rFVIIa on intraoperative blood loss and mortality in patients with severe acute pancreatitis.
    Lu J; Liao LM; Geng YX; Wang X; Tong ZH; Ke L; Li WQ; Li N; Li JS
    Thromb Res; 2014 Apr; 133(4):574-8. PubMed ID: 24457144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
    Filan PM; Mills JF; Clarnette TD; Ekert H; Ekert P
    J Pediatr; 2005 Dec; 147(6):857-9. PubMed ID: 16356448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of life-threatening pulmonary bleeding with activated recombinant factor VII.
    Kamphuisen PW; van den Akker JM; Kaasjager KA; Bloemen TI
    Am J Med; 2002 Mar; 112(4):332-3. PubMed ID: 11893382
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of traumatic bleeding with recombinant factor VIIa.
    Kenet G; Walden R; Eldad A; Martinowitz U
    Lancet; 1999 Nov; 354(9193):1879. PubMed ID: 10584732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
    De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S
    Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant factor VIIa in severe uremic bleeding.
    Révész T; Arets B; Bierings M; van den Bos C; Duval E
    Thromb Haemost; 1998 Aug; 80(2):353. PubMed ID: 9716175
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
    von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury.
    Christians K; Brasel K; Garlitz J; Abu-Hajir M; Gottschall J
    J Trauma; 2005 Sep; 59(3):742-6. PubMed ID: 16361923
    [No Abstract]   [Full Text] [Related]  

  • 19. How we manage requests for recombinant factor VIIa (NovoSeven).
    Mathew P; Simon TL; Hunt KE; Crookston KP
    Transfusion; 2007 Jan; 47(1):8-14. PubMed ID: 17207224
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor VIIa (recombinant) for acute traumatic hemorrhage.
    Patanwala AE
    Am J Health Syst Pharm; 2008 Sep; 65(17):1616-23. PubMed ID: 18714107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.